FLT3 mutation Assay Laboratory Cross Validation: Results from the CALGB 10603/Ratify Trial in Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)

被引：6

作者：

Thiede, Christian ^{[1
]}

Prior, Thomas W. ^{[2
]}

Lavorgna, Serena ^{[3
]}

Krauter, Juergen ^{[4
]}

Barragan, Eva ^{[5
]}

Nomdedeu, Josep ^{[6
]}

Jansen, Joop H. ^{[7
]}

Wei, Andrew H. ^{[8
,9
]}

Zhao, Weiqiang ^{[2
]}

Li, Xiaohong ^{[10
]}

Pallaud, Celine ^{[11
]}

Tiecke, Eva ^{[10
]}

Larson, Richard A. ^{[12
]}

Bloomfield, Clara D. ^{[2
]}

Doehner, Hartmut ^{[13
]}

Ehninger, Gerhard ^{[14
]}

Stone, Richard M. ^{[15
]}

Doehner, Konstanze ^{[13
]}

机构：

[1] Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany

[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[3] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy

[4] Municipal Hosp Braunschweig, Dept Internal Med 3, Braunschweig, Germany

[5] Hosp Univ La Fe Valencia, Dept Hematol, Valencia, Spain

[6] Univ Barcelona, Hematol Dept, Hosp Santa Creu & St Pau, Barcelona, Spain

[7] Radboud Univ Nijmegen, Med Ctr, Lab Hematol, Dept Lab Med, Nijmegen, Netherlands

[8] Alfred Hosp, Dept Clin Haematol, Melbourne, Vic, Australia

[9] Monash Univ, Melbourne, Vic, Australia

[10] Novartis Pharmaceut, Basel, Switzerland

[11] Novartis Pharmaceut, Oncol Precis Med, Novartis Oncol BU, Basel, Switzerland

[12] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA

[13] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[14] Univ Klinikum Carl Gustav Carus TU Dresden, Med Klin & Poliklin 1, Dresden, Germany

[15] Dana Farber Partners Canc Care, Boston, MA USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-112127

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2800

引用

页数：2